Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes
Wednesday Aug 30, 2023
Wednesday Aug 30, 2023
touchCLINICAL PERSPECTIVES for touchNEUROLOGY
Listen to two case-based interviews with migraine specialists focusing on preventive treatment of migraine with anti-CGRP antibodies. In the first, a clinical expert shares his perspectives on treatment failure in patients with migraine, providing insights and guidance, while the second discussion considers different clinical scenarios to focus on practical management.
The experts:
- Prof. Christian Lampl, Konventhospital Barmherzige Brüder, Linz, Austria
- Dr Simy Parikh, Thomas Jefferson University Hospital, Philadelphia, PA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an educational grant from Eli Lilly and Company Limited. This medical education is provided by touchIME.
For further information visit our website:
https://touchneurology.com/the-role-of-anti-CGRP-antibodies-in-migraine-prevention/
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.